Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2019

Feb 6, 2019

29745_dirs_2019-02-05_90238d0e-9a75-407b-befa-e9c9aacc186e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2019-02-01

Reporting Person: Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-01 Common Stock M 12222 Acquired 136756 Direct
2019-02-01 Common Stock F 5476 $119.86 Disposed 131280 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-01 Restricted Stock Unit $ M 12222 Disposed 2019-02-01 Common Stock (12222.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5159 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.